Literature DB >> 17664902

The influence of gluten: weaning recommendations for healthy children and children at risk for celiac disease.

Stefano Guandalini1.   

Abstract

In most developed countries, gluten is currently most commonly introduced between 4 and 6 months of age, in spite of little evidence to support this practice. As for infants at risk of developing food allergies, there is clear evidence that introducing solid foods before the end of the 3rd month is detrimental and should be avoided. A recent growing body of evidence however challenges the notion that solids (and among them, gluten-containing foods) should be introduced beyond the 6th month of life. Another important aspect of gluten introduction into the diet has to do with its possible role in causing type-1 diabetes (IDDM). Recently, a large epidemiological investigation in a cohort of children at risk for IDDM found that exposure to cereals (rice, wheat, oats, barley, rye) that occurred early (< or = 3 months) as well as late (> or = 7 months) resulted in a significantly higher risk of the appearance of islet cell autoimmunity compared to the introduction between 4 and 6 months. As for celiac disease, the protective role of breastfeeding can be considered ascertained, especially the protection offered by having gluten introduced while breastfeeding is continued. Evidence is emerging that early (< or = 3 months) and perhaps even late (7 months or after) first exposure to gluten may favor the onset of celiac disease in predisposed individuals. Additionally, large amounts of gluten at weaning are associated with an increased risk of developing celiac disease, as documented in studies from Scandinavian countries. In celiac children observed in our center, we could show that breastfeeding at the time of gluten introduction delays the appearance of celiac disease and makes it less likely that its presentation is predominantly gastrointestinal. Based on current evidence, it appears reasonable to recommend that gluten be introduced in small amounts in the diet between 4 and 6 months, while the infant is breastfed, and that breastfeeding is continued for at least a further 2-3 months.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664902     DOI: 10.1159/000106366

Source DB:  PubMed          Journal:  Nestle Nutr Workshop Ser Pediatr Program        ISSN: 1661-6677


  8 in total

1.  Influence of breastfeeding versus formula feeding on lymphocyte subsets in infants at risk of coeliac disease: the PROFICEL study.

Authors:  Tamara Pozo-Rubio; Amalia Capilla; Jorge R Mujico; Giada de Palma; Ascensión Marcos; Yolanda Sanz; Isabel Polanco; Maria Dolores García-Novo; Gemma Castillejo; Carmen Ribes-Koninckx; Vicente Varea; Francesc Palau; Luis Ortigosa; Luis Peña-Quintana; Esther Nova
Journal:  Eur J Nutr       Date:  2012-05-11       Impact factor: 5.614

Review 2.  The spectrum of celiac disease: epidemiology, clinical aspects and treatment.

Authors:  Greetje J Tack; Wieke H M Verbeek; Marco W J Schreurs; Chris J J Mulder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-09       Impact factor: 46.802

Review 3.  Effect of the timing of gluten introduction on the development of celiac disease.

Authors:  Marco Silano; Carlo Agostoni; Stefano Guandalini
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

4.  Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen.

Authors:  Ingrid M Zöller-Utz; Birgit Esslinger; Anja Schulze-Krebs; Walburga Dieterich
Journal:  J Clin Immunol       Date:  2009-11-27       Impact factor: 8.317

Review 5.  Pathophysiology of celiac disease.

Authors:  Sonia S Kupfer; Bana Jabri
Journal:  Gastrointest Endosc Clin N Am       Date:  2012-08-30

Review 6.  Human Breast Milk: From Food to Active Immune Response With Disease Protection in Infants and Mothers.

Authors:  Gatien A G Lokossou; Léonce Kouakanou; Anne Schumacher; Ana C Zenclussen
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

Review 7.  Immune development and intestinal microbiota in celiac disease.

Authors:  Tamara Pozo-Rubio; Marta Olivares; Esther Nova; Giada De Palma; Jorge R Mujico; Maria Desamparados Ferrer; Ascensión Marcos; Yolanda Sanz
Journal:  Clin Dev Immunol       Date:  2012-09-11

8.  Italian family paediatricians' approach and management of celiac disease: a cross-sectional study in Puglia Region, 2012.

Authors:  Francesca Fortunato; Domenico Martinelli; Vanessa Cozza; Pierpaolo Ciavarella; Anna Valente; Teresa Cazzato; Ruggiero Piazzolla; Rosa Prato; Biagio Pedalino
Journal:  BMC Gastroenterol       Date:  2014-02-20       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.